Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

SHSCX:US

35.94 USD 0.03 0.08%

As of 09:29:30 ET on 05/24/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHSCX)

Year To Date: +23.00% 3-Month: +12.88% 3-Year: +18.73% 52-Week Range: 25.67 - 36.32
1-Month: +2.54% 1-Year: +35.95% 5-Year: +12.52% Beta vs SPX: 0.85

Mutual Fund Chart for SHSCX

No chart data available.
  • SHSCX:US 35.94
  • 1M
  • 1Y
Interactive SHSCX Chart

Previous Close

Fund Profile & Information for SHSCX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 12-21-1999 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrock.com

Fundamentals for SHSCX

NAV (on 2013-05-24) 35.94
Assets (M) (on 2013-05-24) 2,663.63
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for SHSCX

No dividends reported

Fees & Expenses for SHSCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.73
Redemption Fee 1.00
12b1 Fee 1.00
Expense Ratio 2.01

Top Fund Holdings for SHSCX

Filing Date: 12/31/2012
Name Position Value % of Total
Pfizer Inc 4,340,140 108,850,711 5.513%
Eli Lilly & Co 1,603,600 79,089,552 4.005%
Johnson & Johnson 1,043,900 73,177,390 3.706%
Roche Holding AG 353,600 71,491,268 3.621%
Sanofi 735,200 69,719,311 3.531%
Celgene Corp 748,152 58,894,525 2.983%
Novartis AG 833,900 52,680,203 2.668%
Express Scripts Holding Co 920,447 49,704,138 2.517%
Alexion Pharmaceuticals Inc 495,101 46,445,425 2.352%
Biogen Idec Inc 309,400 45,379,698 2.298%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil